InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the complete record of transactions filed by Shearman Mark S, Vice-Président Exécutif. Director active across 1 companies, notably Editas Medicine, Inc.. Aggregated, 7 reports have been logged. Total volume traded: €49k. The latest transaction was disclosed on 15 June 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€49,4875,145 shares@ €9.61850.025% mcap100.0% of flow
Common Stock
SEC:0001415889-22-006631:0·
031,709 shares0
Common Stock
SEC:0001415889-22-001224·
031,709 shares0
Common Stock
SEC:0001415889-22-001224:0·
09,084 shares0
Common Stock
SEC:0001179110-21-011225·
09,084 shares0
Common Stock
SEC:0001179110-21-011225:0·
032,701 shares0
Common Stock
SEC:0001179110-21-006778·
032,701 shares0
Common Stock
SEC:0001179110-21-006778:0·
7 of 7 declarations
About Shearman Mark S
Mark S. Shearman is the Executive Vice President and Chief Scientific Officer at Editas Medicine, Inc. He oversees the company's research and development activities, focusing on innovation and scientific advancement. With a strong background in the biopharmaceutical sector, he plays a key role in developing new therapies. His expertise is essential in guiding research and development initiatives.
